Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment

Neurobiology of Disease

Volumn 25, Issue 2, 2007, Pages 427-437

  Woltjer, Randall L ^a   McMahan, Wendy ^a   Milatovic, Dejan ^a   Kjerulf, John D ^a   Shie, Feng Shiun ^a   Rung, Lisa G ^a   Montine, Kathleen S ^a   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Antioxidants; Chaperones; Unfolded protein response

Indexed keywords

4 PHENYLBUTYRIC ACID; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; CHAPERONE; DETERGENT; GLYCEROL; THIOCTIC ACID; TRIMETHYLAMINE OXIDE;

ALZHEIMER DISEASE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; SOLUBILITY;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANTIOXIDANTS; CELL LINE; DETERGENTS; HUMANS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEIN FOLDING; SENILE PLAQUES; SOLUBILITY;

EID: 33846301100     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.10.003     Document Type: Article

References (75)

1. Allsop D., Landon M., and Kidd M. The isolation and amino acid composition of senile plaque core protein. Brain Res. 259 (1983) 348-352
2. Bieschke J., Zhang Q., Powers E.T., Lerner R.A., and Kelly J.W. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44 (2005) 4977-4983
3. Bonapace G., Waheed A., Shah G.N., and Sly W.S. Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12300-12305
4. Brown C.R., Hong-Brown L.Q., Biwersi J., Verkman A.S., and Welch W.J. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1 (1996) 117-125
5. Brown C.R., Hong-Brown L.Q., and Welch W.J. Correcting temperature-sensitive protein folding defects. J. Clin. Invest. 99 (1997) 1432-1444
6. Buckig A., Tikkanen R., Herzog V., and Schmitz A. Cytosolic and nuclear aggregation of the amyloid beta-peptide following its expression in the endoplasmic reticulum. Histochem. Cell Biol. 118 (2002) 353-360
7. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., and Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267 (1992) 546-554
8. Burrows J.A., Willis L.K., and Perlmutter D.H. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1796-1801
9. Bush A.I., Pettingell W.H., Multhaup G., d Paradis M., Vonsattel J.P., Gusella J.F., Beyreuther K., Masters C.L., and Tanzi R.E. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265 (1994) 1464-1467
10. Butterfield D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radical Res. 36 (2002) 1307-1313
11. Calfon M., Zeng H., Urano F., Till J.H., Hubbard S.R., Harding H.P., Clark S.G., and Ron D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415 (2002) 92-96
12. Cao G., and Prior R.L. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol. 299 (1999) 50-62
13. Carlberg I., and Mannervik B. Glutathione reductase. Methods Enzymol. 113 (1985) 484-490
14. Caughey B., and Raymond G.J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67 (1993) 643-650
15. Chakravarthi S., and Bulleid N.J. Glutathione is required to regulate the formation of native disulfide bonds within proteins entering the secretory pathway. J. Biol. Chem. 279 (2004) 39872-39879
16. Chaudhuri T.K., and Paul S. Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J. 273 (2006) 1331-1349
17. Cuozzo J.W., and Kaiser C.A. Competition between glutathione and protein thiols for disulphide-bond formation. Nat. Cell Biol. 1 (1999) 130-135
18. Davis J.B. Oxidative mechanisms in beta-amyloid cytotoxicity. Neurodegeneration 5 (1996) 441-444
19. Dikalov S.I., Vitek M.P., and Mason R.P. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radical Biol. Med. 36 (2004) 340-347
20. Drake J., Link C.D., and Butterfield D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging 24 (2003) 415-420
21. Dyrks T., Dyrks E., Hartmann T., Masters C., and Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267 (1992) 18210-18217
22. Fan J.Q., Ishii S., Asano N., and Suzuki Y. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 5 (1999) 112-115
23. Fernandez-Pachon M.S., Villano D., Troncoso A.M., and Garcia-Parrilla M.C. Antioxidant capacity of plasma after red wine intake in human volunteers. J. Agric. Food Chem. 53 (2005) 5024-5029
24. Fischer H., Fukuda N., Barbry P., Illek B., Sartori C., and Matthay M.A. Partial restoration of defective chloride conductance in DeltaF508 CF mice by trimethylamine oxide. Am. J. Physiol., Lung Cell. Mol. Physiol. 281 (2001) L52-L57
25. Foster B.A., Coffey H.A., Morin M.J., and Rastinejad F. Pharmacological rescue of mutant p53 conformation and function. Science 286 (1999) 2507-2510
26. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
27. Hammarstrom P., Wiseman R.L., Powers E.T., and Kelly J.W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299 (2003) 713-716
28. Hamos J.E., Oblas B., Pulaski-Salo D., Welch W.J., Bole D.G., and Drachman D.A. Expression of heat shock proteins in Alzheimer's disease. Neurology 41 (1991) 345-350
29. Hoozemans J.J., Veerhuis R., Van Haastert E.S., Rozemuller J.M., Baas F., Eikelenboom P., and Scheper W. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. (Berl.) 110 (2005) 165-172
30. Jarrett J.T., Berger E.P., and Lansbury Jr. P.T. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32 (1993) 4693-4697
31. Jessop C.E., and Bulleid N.J. Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 279 (2004) 55341-55347
32. Jin L.W., Hua D.H., Shie F.S., Maezawa I., Sopher B., and Martin G.M. Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death. J. Mol. Neurosci. 19 (2002) 57-61
33. Jin L.W., Shie F.S., Maezawa I., Vincent I., and Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol. 164 (2004) 975-985
34. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., Morihara T., Yoneda T., Gomi F., Mori Y., Nakano Y., Takeda J., Tsuda T., Itoyama Y., Murayama O., Takashima A., St George-Hyslop P., Takeda M., and Tohyama M. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat. Cell Biol. 1 (1999) 479-485
35. Klein W.L. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41 (2002) 345-352
36. Kokubo H., Kayed R., Glabe C.G., and Yamaguchi H. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res. 1031 (2005) 222-228
37. Lea M.A., and Randolph V.M. Induction of reporter gene expression by inhibitors of histone deacetylase. Anticancer Res. 18 (1998) 2717-2722
38. Lea M.A., and Tulsyan N. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. Anticancer Res. 15 (1995) 879-883
39. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury Jr. P.T., and Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 4 (1998) 730-734
40. Lim M., McKenzie K., Floyd A.D., Kwon E., and Zeitlin P.L. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids. Am. J. Respir. Cell Mol. Biol. 31 (2004) 351-357
41. Liu X.L., Done S.C., Yan K., Kilpelainen P., Pikkarainen T., and Tryggvason K. Defective trafficking of nephrin missense mutants rescued by a chemical chaperone. J. Am. Soc. Nephrol. 15 (2004) 1731-1738
42. Maezawa I., Jin L.W., Woltjer R.L., Maeda N., Martin G.M., Montine T.J., and Montine K.S. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J. Neuorchem. 91 (2004) 1312-1321
43. Maezawa I., Hong H.S., Wu H.C., Battina S.K., Rana S., Iwamoto T., Radke G.A., Pettersson E., Martin G.M., Hua D.H., and Jin L.W. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J. Neurochem. 98 (2006) 57-67
44. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., and Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61 (1993) 1171-1174
45. Marr N., Kamsteeg E.J., van Raak M., van Os C.H., and Deen P.M. Functionality of aquaporin-2 missense mutants in recessive nephrogenic diabetes insipidus. Pflugers Arch. 442 (2001) 73-77
46. McLellan M.E., Kajdasz S.T., Hyman B.T., and Bacskai B.J. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J. Neurosci. 23 (2003) 2212-2217
47. Molteni S.N., Fassio A., Ciriolo M.R., Filomeni G., Pasqualetto E., Fagioli C., and Sitia R. Glutathione limits Ero1-dependent oxidation in the endoplasmic reticulum. J. Biol. Chem. 279 (2004) 32667-32673
48. Morello J.P., Petaja-Repo U.E., Bichet D.G., and Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol. Sci. 21 (2000) 466-469
49. Niwa M., Sidrauski C., Kaufman R.J., and Walter P. A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell 99 (1999) 691-702
50. Paschen W. Endoplasmic reticulum: a primary target in various acute disorders and degenerative diseases of the brain. Cell Calcium. 34 (2003) 365-383
51. Paschen W. Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis. Curr. Neurovasc. Res. 1 (2004) 173-181
52. Pogocki D. Alzheimer's beta-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects. Acta Neurobiol. Exp. (Wars.) 63 (2003) 131-145
53. Prior R.L., and Cao G. Analysis of botanicals and dietary supplements for antioxidant capacity: a review. J. AOAC Int. 83 (2000) 950-956
54. Priola S.A., Raines A., and Caughey W.S. Porphyrin and phthalocyanine antiscrapie compounds. Science 287 (2000) 1503-1506
55. Rubenstein R.C., Egan M.E., and Zeitlin P.L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest. 100 (1997) 2457-2465
56. Sato S., Ward C.L., Krouse M.E., Wine J.J., and Kopito R.R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271 (1996) 635-638
57. Sato N., Urano F., Yoon Leem J., Kim S.H., Li M., Donoviel D., Bernstein A., Lee A.S., Ron D., Veselits M.L., Sisodia S.S., and Thinakaran G. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat. Cell Biol. 2 (2000) 863-870
58. Sawkar A.R., Cheng W.C., Beutler E., Wong C.H., Balch W.E., and Kelly J.W. Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15428-15433
59. Shang J. Quantitative measurement of events in the mammalian unfolded protein response. Methods 35 (2005) 390-394
60. Sopher B.L., Fukuchi K., Smith A.C., Leppig K.A., Furlong C.E., and Martin G.M. Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res. Mol. Brain Res. 26 (1994) 207-217
61. Sopher B.L., Fukuchi K., Kavanagh T.J., Furlong C.E., and Martin G.M. Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death. Mol. Chem. Neuropathol. 29 (1996) 153-168
62. Spiess C., Meyer A.S., Reissmann S., and Frydman J. Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. Trends Cell Biol. 14 (2004) 598-604
63. Supattapone S., Nguyen H.O., Cohen F.E., Prusiner S.B., and Scott M.R. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14529-14534
64. Tamarappoo B.K., and Verkman A.S. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J. Clin. Invest. 101 (1998) 2257-2267
65. Tatzelt J., Prusiner S.B., and Welch W.J. Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J. 15 (1996) 6363-6373
66. Varadarajan S., Yatin S., Aksenova M., and Butterfield D.A. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130 (2000) 184-208
67. Vilatoba M., Eckstein C., Bilbao G., Smyth C.A., Jenkins S., Thompson J.A., Eckhoff D.E., and Contreras J.L. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 138 (2005) 342-351
68. Wang J., Dickson D.W., Trojanowski J.Q., and Lee V.M. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158 (1999) 328-337
69. Welch W.J. Role of quality control pathways in human diseases involving protein misfolding. Semin. Cell Dev. Biol. 15 (2004) 31-38
70. Woltjer R.L., Maezawa I., Ou J.J., Montine K.S., and Montine T.J. Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. J. Alzheimer's Dis. 5 (2003) 467-476
71. Woltjer R.L., Nghiem W., Maezawa I., Milatovic D., Vaisar T., Montine K.S., and Montine T.J. Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J. Neurochem. 93 (2005) 1047-1056
72. Wyttenbach A., Sauvageot O., Carmichael J., Diaz-Latoud C., Arrigo A.P., and Rubinsztein D.C. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11 (2002) 1137-1151
73. Yang D.S., Yip C.M., Huang T.H., Chakrabartty A., and Fraser P.E. Manipulating the amyloid-beta aggregation pathway with chemical chaperones. J. Biol. Chem. 274 (1999) 32970-32974
74. Yoshida H., Matsui T., Yamamoto A., Okada T., and Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107 (2001) 881-891
75. Yoshida H., Yoshizawa T., Shibasaki F., Shoji S., and Kanazawa I. Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch. Neurobiol. Dis. 10 (2002) 88-99